Serum Institute to conduct Phase 2, 3 clinical trials of Oxford University Covid vaccine

Drugs Controller General of India has given approval to Serum Institute of India, Pune, to conduct Phase 2 and 3 clinical trials of Oxford University-Astra Zeneca,  COVID-19 vaccine in India.